Evaluating Safety and Efficacy of Shortened Dual Antithrombotic Therapy in Atrial Fibrillation
Short dual therapy may reduce bleeding for heart patients
A randomized trial demonstrates that a 1-month dual therapy period significantly reduces bleeding risks without compromising efficacy.
A new trial suggests that a shorter period of dual blood thinners can lower bleeding risks for patients with atrial fibrillation and heart i…
Meta-analysis finds increased bleeding with antithrombotic therapy during breast biopsy, but clinically relevant events are rare
Continuing blood thinners during breast biopsy increases minor bleeding but rarely serious problems
A systematic review and meta-analysis of 8 studies including 11,524 patients undergoing image-guided breast biopsy found that continuing ant…
Continuing blood thinners during a breast biopsy slightly increases minor bleeding but rarely causes serious problems like heart attacks or …